Economic analysis of biological therapies for severe asthma treatment

-

Saved in:
Bibliographic Details
Main Authors: Carlos Almonacid-Sánchez, Carlos Melero-Moreno
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Farmacia Hospitalaria
Online Access:http://www.aulamedica.es/fh/pdf/11342.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846093755028865024
author Carlos Almonacid-Sánchez
Carlos Melero-Moreno
author_facet Carlos Almonacid-Sánchez
Carlos Melero-Moreno
author_sort Carlos Almonacid-Sánchez
collection DOAJ
description -
format Article
id doaj-art-0a4072dab4f3479fabacee1ee4241feb
institution Kabale University
issn 1130-6343
2171-8695
language English
publishDate 2019-11-01
publisher Elsevier
record_format Article
series Farmacia Hospitalaria
spelling doaj-art-0a4072dab4f3479fabacee1ee4241feb2025-01-02T16:24:44ZengElsevierFarmacia Hospitalaria1130-63432171-86952019-11-0143617517610.7399/fh.11342Economic analysis of biological therapies for severe asthma treatmentCarlos Almonacid-Sánchez0Carlos Melero-Moreno1Pneumology Service, Ramón y Cajal University Hospital, Madrid. SpainPneumology Service, 12 de Octubre University Hospital, Madrid. Spain-http://www.aulamedica.es/fh/pdf/11342.pdf
spellingShingle Carlos Almonacid-Sánchez
Carlos Melero-Moreno
Economic analysis of biological therapies for severe asthma treatment
Farmacia Hospitalaria
title Economic analysis of biological therapies for severe asthma treatment
title_full Economic analysis of biological therapies for severe asthma treatment
title_fullStr Economic analysis of biological therapies for severe asthma treatment
title_full_unstemmed Economic analysis of biological therapies for severe asthma treatment
title_short Economic analysis of biological therapies for severe asthma treatment
title_sort economic analysis of biological therapies for severe asthma treatment
url http://www.aulamedica.es/fh/pdf/11342.pdf
work_keys_str_mv AT carlosalmonacidsanchez economicanalysisofbiologicaltherapiesforsevereasthmatreatment
AT carlosmeleromoreno economicanalysisofbiologicaltherapiesforsevereasthmatreatment